Fertility centres are making a massive push to increase preimplantation genetic diagnosis in a bid to eradicate certain diseases.
Victor Fraile/Corbis/Getty
China’s move to a two-child policy has been a boon for fertility clinics.
This is a preview of subscription content, log in via an institution to check access.
Change history
18 August 2017
The photo originally leading this story depicted infants in a hospital in Hong Kong, which was not relevant to the subject matter. It has therefore been deleted.
Related links
Related links
Related links in Nature Research
CRISPR fixes disease gene in viable human embryos 2017-Aug-02
Secrets of life in a spoonful of blood 2017-Feb-07
Should you edit your children’s genes? 2016-Feb-23
Reproductive medicine: The power of three 2014-May-21
Making babies: the next 30 years 2008-Jul-16
Related external links
Rights and permissions
About this article
Cite this article
Cyranoski, D. China’s embrace of embryo selection raises thorny questions. Nature 548, 272–274 (2017). https://doi.org/10.1038/548272a
Published:
Issue Date:
DOI: https://doi.org/10.1038/548272a
- Springer Nature Limited
This article is cited by
-
Changing Fertility Landscapes: Exploring the Reproductive Routes and Choices of Fertility Patients from China for Assisted Reproduction in Russia
Asian Bioethics Review (2021)
-
Is selecting better than modifying? An investigation of arguments against germline gene editing as compared to preimplantation genetic diagnosis
BMC Medical Ethics (2019)
-
Better beings?
Nature Biotechnology (2017)
-
Query the merits of embryo editing for reproductive research now
Nature Biotechnology (2017)